About PSM
PSM Vice President Expecting Full House for Counterfeit Drug Conference
Each year, Partnership for Safe Medicines Vice President Dr. Bryan Liang hosts a health policy conference in San Diego. We’re happy to report that all seats have been filled for his March 26, 2010 conference, “Pharmaceutical Crime: Investigating and Prosecuting Drug Diversion and Counterfeiting,” sponsored by the Institute of Health Law Studies at the California…
[...]Partnership for Safe Medicines Applauds Google’s Updated U.S. Pharmaceutical Advertising Policy
WASHINGTON, DC – Feb. 10, 2010 – The Partnership for Safe Medicines (PSM) today commended Google for its updated policy on U.S. pharmaceutical advertising through its paid search program, AdWords. Toward the end of the month, Google will refine its advertising model to accept ads only from online pharmacies in the U.S. that are accredited…
[...]Partnerka, Counterfeit Drugs and the New Counterfeit Spam
The Partnership for Safe Medicines (PSM) has long reported on the growing issue of pharmaceutical spam advertising—and now SophosLab Canada has taken a closer look at the solicitation of counterfeit products online.
[...]Consumer Protection Group Applauds International Efforts to Combat Illegal Online Pharmacies
The Partnership for Safe Medicines (PSM) issued the following statement regarding the International Internet Week of Action, code named Operation Pangea II, intended to curb illegal actions involving medical products. PSM is a group of organizations and individuals dedicated to protecting consumers from counterfeit medicines.
[...]“Safe” Country Focus: United Kingdom
As my colleague Thomas Kubic recently noted, most supporters of drug importation have a faulty assumption that developed countries like Canada, Australia, Japan and the 27 members of the European Union (E.U.) are insulated from the global threat of counterfeit drugs. In the coming weeks, we will take a closer look at some of these so-called “safe” countries and illustrate why there is no such thing as a “safe” country when it comes to drug importation.
[...]Mapping the World of Counterfeits
Marv D. Shepherd, PhD From intellectual property violations to grave health risks, the Partnership for Safe Medicines (PSM) brings you the facts and figures regarding the harmful effects of counterfeit drugs. One of our most popular tools: the interactive map of counterfeit drug incidents. As a PSM member, the International Anticounterfeiting Coalition (IACC) understands the…
[...]Interview Spotlight: Building Pharmaceutical Anti-Counterfeiting Programs
Dr. Frances Richmond from the University of Southern California (USC) School of Pharmacy and Lew Kontnik of Amgen are the organizers of the upcoming “Building Pharmaceutical Anti-Counterfeiting Programs” course, which will take place on Nov. 18 at USC.
[...]PSAs Warn Cambodians of Counterfeit Drug Dangers
Earlier this month, a public health campaign was launched in Cambodia to help raise awareness and combat the rising threat of counterfeit drugs throughout Southeast Asia. The campaign, launched by the U.S. Agency for International Development (USAID) and the United States Pharmacopeia (USP) Convention with the support of Cambodian authorities, includes a nationally broadcasted public service announcement (PSA) series titled “Pharmacide.”
[...]Internet Search Engines Promote Illegal Online Pharmacies
The Partnership for Safe Medicines, a group of organizations and individuals dedicated to protecting consumers from counterfeit medicines, issued the following statement regarding recent reports released by LegitScript, an online pharmacy verification service, and KnujOn,an Internet compliance company, which found that 80 to 90 percent of search engine-sponsored advertisements of online drug pharmacies violate federal and state laws, including selling substandard or counterfeit drugs to unsuspecting consumers.
[...]No Such Thing as a “Safe Country” for Drug Importation
With talks about drug importation continuing in Congress, drug importation supporters argue that if the United States allows importation only from “safe countries,” such as Canada and the United Kingdom, than most of drug safety concerns would be eliminated. However, when it comes to drug importation, there is no such thing as a “safe” country.
[...]